Global Acute Myeloid Leukaemia Therapeutics Market Growth (Status and Outlook) 2026-2032
The global Acute Myeloid Leukaemia Therapeutics market size is predicted to grow from US$ 4555 million in 2025 to US$ 9391 million in 2032; it is expected to grow at a CAGR of 11.1% from 2026 to 2032.
United States market for Acute Myeloid Leukaemia Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Acute Myeloid Leukaemia Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Acute Myeloid Leukaemia Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Acute Myeloid Leukaemia Therapeutics players cover Pfizer Inc., Novartis AG, Celgene Corporation, Astellas Pharma Inc., Daiichi Sankyo Company, Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Acute Myeloid Leukaemia Therapeutics Industry Forecast? looks at past sales and reviews total world Acute Myeloid Leukaemia Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Acute Myeloid Leukaemia Therapeutics sales for 2026 through 2032. With Acute Myeloid Leukaemia Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Myeloid Leukaemia Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Acute Myeloid Leukaemia Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acute Myeloid Leukaemia Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Acute Myeloid Leukaemia Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Myeloid Leukaemia Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Myeloid Leukaemia Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Myeloid Leukaemia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Acute Myeloid Leukaemia Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Acute Myeloid Leukaemia Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Acute Myeloid Leukaemia Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Acute Myeloid Leukaemia Therapeutics players cover Pfizer Inc., Novartis AG, Celgene Corporation, Astellas Pharma Inc., Daiichi Sankyo Company, Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Acute Myeloid Leukaemia Therapeutics Industry Forecast? looks at past sales and reviews total world Acute Myeloid Leukaemia Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Acute Myeloid Leukaemia Therapeutics sales for 2026 through 2032. With Acute Myeloid Leukaemia Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Myeloid Leukaemia Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Acute Myeloid Leukaemia Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acute Myeloid Leukaemia Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Acute Myeloid Leukaemia Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Myeloid Leukaemia Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Myeloid Leukaemia Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Myeloid Leukaemia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hypomethylating Agents
- Others
- Specialty Clinics
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Novartis AG
- Celgene Corporation
- Astellas Pharma Inc.
- Daiichi Sankyo Company, Limited
- Jazz Pharmaceuticals
- Boehringer Ingelheim International GmbH
- Johnson & Johnson
- Gilead Sciences, Inc.
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
- Sunesis Pharmaceuticals, Inc.
- Agios Pharmaceuticals, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Myeloid Leukaemia Therapeutics Market Size (2021-2032)
2.1.2 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Acute Myeloid Leukaemia Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Acute Myeloid Leukaemia Therapeutics Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hypomethylating Agents
2.2.5 Others
2.2.6 Acute Myeloid Leukaemia Therapeutics Market Size by Type
2.2.6.1 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Acute Myeloid Leukaemia Therapeutics Segment by Application
2.3.1 Specialty Clinics
2.3.2 Hospital
2.3.3 Others
2.3.4 Acute Myeloid Leukaemia Therapeutics Market Size by Application
2.3.4.1 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
3 ACUTE MYELOID LEUKAEMIA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Player
3.1.1 Global Acute Myeloid Leukaemia Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Acute Myeloid Leukaemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACUTE MYELOID LEUKAEMIA THERAPEUTICS BY REGION
4.1 Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026)
4.2 Global Acute Myeloid Leukaemia Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
4.4 APAC Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
4.5 Europe Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026)
5.2 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
5.3 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026)
6.2 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
6.3 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026)
7.2 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
7.3 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Myeloid Leukaemia Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACUTE MYELOID LEUKAEMIA THERAPEUTICS MARKET FORECAST
10.1 Global Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Acute Myeloid Leukaemia Therapeutics Forecast
10.1.3 APAC Acute Myeloid Leukaemia Therapeutics Forecast
10.1.4 Europe Acute Myeloid Leukaemia Therapeutics Forecast
10.1.5 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Forecast
10.2 Americas Acute Myeloid Leukaemia Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Acute Myeloid Leukaemia Therapeutics Forecast
10.2.2 Canada Market Acute Myeloid Leukaemia Therapeutics Forecast
10.2.3 Mexico Market Acute Myeloid Leukaemia Therapeutics Forecast
10.2.4 Brazil Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3 APAC Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.3.1 China Acute Myeloid Leukaemia Therapeutics Market Forecast
10.3.2 Japan Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.3 Korea Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.4 Southeast Asia Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.5 India Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.6 Australia Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4 Europe Acute Myeloid Leukaemia Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.2 France Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.3 UK Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.4 Italy Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.5 Russia Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5.2 South Africa Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5.3 Israel Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5.4 Turkey Market Acute Myeloid Leukaemia Therapeutics Forecast
10.6 Global Acute Myeloid Leukaemia Therapeutics Forecast by Type (2027-2032)
10.7 Global Acute Myeloid Leukaemia Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Acute Myeloid Leukaemia Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.1.3 Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Acute Myeloid Leukaemia Therapeutics Product Offered
11.2.3 Novartis AG Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Information
11.3.2 Celgene Corporation Acute Myeloid Leukaemia Therapeutics Product Offered
11.3.3 Celgene Corporation Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Celgene Corporation Main Business Overview
11.3.5 Celgene Corporation Latest Developments
11.4 Astellas Pharma Inc.
11.4.1 Astellas Pharma Inc. Company Information
11.4.2 Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.4.3 Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Astellas Pharma Inc. Main Business Overview
11.4.5 Astellas Pharma Inc. Latest Developments
11.5 Daiichi Sankyo Company, Limited
11.5.1 Daiichi Sankyo Company, Limited Company Information
11.5.2 Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Product Offered
11.5.3 Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Daiichi Sankyo Company, Limited Main Business Overview
11.5.5 Daiichi Sankyo Company, Limited Latest Developments
11.6 Jazz Pharmaceuticals
11.6.1 Jazz Pharmaceuticals Company Information
11.6.2 Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Product Offered
11.6.3 Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jazz Pharmaceuticals Main Business Overview
11.6.5 Jazz Pharmaceuticals Latest Developments
11.7 Boehringer Ingelheim International GmbH
11.7.1 Boehringer Ingelheim International GmbH Company Information
11.7.2 Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Product Offered
11.7.3 Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Boehringer Ingelheim International GmbH Main Business Overview
11.7.5 Boehringer Ingelheim International GmbH Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Product Offered
11.8.3 Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Gilead Sciences, Inc.
11.9.1 Gilead Sciences, Inc. Company Information
11.9.2 Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.9.3 Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Gilead Sciences, Inc. Main Business Overview
11.9.5 Gilead Sciences, Inc. Latest Developments
11.10 Amgen Inc.
11.10.1 Amgen Inc. Company Information
11.10.2 Amgen Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.10.3 Amgen Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Amgen Inc. Main Business Overview
11.10.5 Amgen Inc. Latest Developments
11.11 Takeda Pharmaceutical Company Limited
11.11.1 Takeda Pharmaceutical Company Limited Company Information
11.11.2 Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Product Offered
11.11.3 Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.11.5 Takeda Pharmaceutical Company Limited Latest Developments
11.12 Sunesis Pharmaceuticals, Inc.
11.12.1 Sunesis Pharmaceuticals, Inc. Company Information
11.12.2 Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.12.3 Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sunesis Pharmaceuticals, Inc. Main Business Overview
11.12.5 Sunesis Pharmaceuticals, Inc. Latest Developments
11.13 Agios Pharmaceuticals, Inc.
11.13.1 Agios Pharmaceuticals, Inc. Company Information
11.13.2 Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.13.3 Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Agios Pharmaceuticals, Inc. Main Business Overview
11.13.5 Agios Pharmaceuticals, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Myeloid Leukaemia Therapeutics Market Size (2021-2032)
2.1.2 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Acute Myeloid Leukaemia Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Acute Myeloid Leukaemia Therapeutics Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hypomethylating Agents
2.2.5 Others
2.2.6 Acute Myeloid Leukaemia Therapeutics Market Size by Type
2.2.6.1 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Acute Myeloid Leukaemia Therapeutics Segment by Application
2.3.1 Specialty Clinics
2.3.2 Hospital
2.3.3 Others
2.3.4 Acute Myeloid Leukaemia Therapeutics Market Size by Application
2.3.4.1 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
3 ACUTE MYELOID LEUKAEMIA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Player
3.1.1 Global Acute Myeloid Leukaemia Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Acute Myeloid Leukaemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACUTE MYELOID LEUKAEMIA THERAPEUTICS BY REGION
4.1 Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026)
4.2 Global Acute Myeloid Leukaemia Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
4.4 APAC Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
4.5 Europe Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026)
5.2 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
5.3 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026)
6.2 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
6.3 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026)
7.2 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
7.3 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Myeloid Leukaemia Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACUTE MYELOID LEUKAEMIA THERAPEUTICS MARKET FORECAST
10.1 Global Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Acute Myeloid Leukaemia Therapeutics Forecast
10.1.3 APAC Acute Myeloid Leukaemia Therapeutics Forecast
10.1.4 Europe Acute Myeloid Leukaemia Therapeutics Forecast
10.1.5 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Forecast
10.2 Americas Acute Myeloid Leukaemia Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Acute Myeloid Leukaemia Therapeutics Forecast
10.2.2 Canada Market Acute Myeloid Leukaemia Therapeutics Forecast
10.2.3 Mexico Market Acute Myeloid Leukaemia Therapeutics Forecast
10.2.4 Brazil Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3 APAC Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.3.1 China Acute Myeloid Leukaemia Therapeutics Market Forecast
10.3.2 Japan Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.3 Korea Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.4 Southeast Asia Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.5 India Market Acute Myeloid Leukaemia Therapeutics Forecast
10.3.6 Australia Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4 Europe Acute Myeloid Leukaemia Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.2 France Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.3 UK Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.4 Italy Market Acute Myeloid Leukaemia Therapeutics Forecast
10.4.5 Russia Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5.2 South Africa Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5.3 Israel Market Acute Myeloid Leukaemia Therapeutics Forecast
10.5.4 Turkey Market Acute Myeloid Leukaemia Therapeutics Forecast
10.6 Global Acute Myeloid Leukaemia Therapeutics Forecast by Type (2027-2032)
10.7 Global Acute Myeloid Leukaemia Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Acute Myeloid Leukaemia Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.1.3 Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Acute Myeloid Leukaemia Therapeutics Product Offered
11.2.3 Novartis AG Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Information
11.3.2 Celgene Corporation Acute Myeloid Leukaemia Therapeutics Product Offered
11.3.3 Celgene Corporation Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Celgene Corporation Main Business Overview
11.3.5 Celgene Corporation Latest Developments
11.4 Astellas Pharma Inc.
11.4.1 Astellas Pharma Inc. Company Information
11.4.2 Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.4.3 Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Astellas Pharma Inc. Main Business Overview
11.4.5 Astellas Pharma Inc. Latest Developments
11.5 Daiichi Sankyo Company, Limited
11.5.1 Daiichi Sankyo Company, Limited Company Information
11.5.2 Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Product Offered
11.5.3 Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Daiichi Sankyo Company, Limited Main Business Overview
11.5.5 Daiichi Sankyo Company, Limited Latest Developments
11.6 Jazz Pharmaceuticals
11.6.1 Jazz Pharmaceuticals Company Information
11.6.2 Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Product Offered
11.6.3 Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jazz Pharmaceuticals Main Business Overview
11.6.5 Jazz Pharmaceuticals Latest Developments
11.7 Boehringer Ingelheim International GmbH
11.7.1 Boehringer Ingelheim International GmbH Company Information
11.7.2 Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Product Offered
11.7.3 Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Boehringer Ingelheim International GmbH Main Business Overview
11.7.5 Boehringer Ingelheim International GmbH Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Product Offered
11.8.3 Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Gilead Sciences, Inc.
11.9.1 Gilead Sciences, Inc. Company Information
11.9.2 Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.9.3 Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Gilead Sciences, Inc. Main Business Overview
11.9.5 Gilead Sciences, Inc. Latest Developments
11.10 Amgen Inc.
11.10.1 Amgen Inc. Company Information
11.10.2 Amgen Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.10.3 Amgen Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Amgen Inc. Main Business Overview
11.10.5 Amgen Inc. Latest Developments
11.11 Takeda Pharmaceutical Company Limited
11.11.1 Takeda Pharmaceutical Company Limited Company Information
11.11.2 Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Product Offered
11.11.3 Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.11.5 Takeda Pharmaceutical Company Limited Latest Developments
11.12 Sunesis Pharmaceuticals, Inc.
11.12.1 Sunesis Pharmaceuticals, Inc. Company Information
11.12.2 Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.12.3 Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sunesis Pharmaceuticals, Inc. Main Business Overview
11.12.5 Sunesis Pharmaceuticals, Inc. Latest Developments
11.13 Agios Pharmaceuticals, Inc.
11.13.1 Agios Pharmaceuticals, Inc. Company Information
11.13.2 Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
11.13.3 Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Agios Pharmaceuticals, Inc. Main Business Overview
11.13.5 Agios Pharmaceuticals, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Acute Myeloid Leukaemia Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Hypomethylating Agents
Table 7. Major Players of Others
Table 8. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Table 11. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Table 14. Global Acute Myeloid Leukaemia Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player (2021-2026)
Table 16. Acute Myeloid Leukaemia Therapeutics Key Players Head office and Products Offered
Table 17. Acute Myeloid Leukaemia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Table 22. Global Acute Myeloid Leukaemia Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country (2021-2026)
Table 26. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Table 28. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Table 30. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Table 32. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country (2021-2026)
Table 36. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Acute Myeloid Leukaemia Therapeutics
Table 42. Key Market Challenges & Risks of Acute Myeloid Leukaemia Therapeutics
Table 43. Key Industry Trends of Acute Myeloid Leukaemia Therapeutics
Table 44. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Pfizer Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 49. Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 50. Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Pfizer Inc. Main Business
Table 52. Pfizer Inc. Latest Developments
Table 53. Novartis AG Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 54. Novartis AG Acute Myeloid Leukaemia Therapeutics Product Offered
Table 55. Novartis AG Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Novartis AG Main Business
Table 57. Novartis AG Latest Developments
Table 58. Celgene Corporation Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 59. Celgene Corporation Acute Myeloid Leukaemia Therapeutics Product Offered
Table 60. Celgene Corporation Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Celgene Corporation Main Business
Table 62. Celgene Corporation Latest Developments
Table 63. Astellas Pharma Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 64. Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 65. Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Astellas Pharma Inc. Main Business
Table 67. Astellas Pharma Inc. Latest Developments
Table 68. Daiichi Sankyo Company, Limited Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 69. Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Product Offered
Table 70. Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Daiichi Sankyo Company, Limited Main Business
Table 72. Daiichi Sankyo Company, Limited Latest Developments
Table 73. Jazz Pharmaceuticals Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 74. Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Product Offered
Table 75. Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Jazz Pharmaceuticals Main Business
Table 77. Jazz Pharmaceuticals Latest Developments
Table 78. Boehringer Ingelheim International GmbH Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 79. Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Product Offered
Table 80. Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Boehringer Ingelheim International GmbH Main Business
Table 82. Boehringer Ingelheim International GmbH Latest Developments
Table 83. Johnson & Johnson Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 84. Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Product Offered
Table 85. Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Gilead Sciences, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 89. Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 90. Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Gilead Sciences, Inc. Main Business
Table 92. Gilead Sciences, Inc. Latest Developments
Table 93. Amgen Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 94. Amgen Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 95. Amgen Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Amgen Inc. Main Business
Table 97. Amgen Inc. Latest Developments
Table 98. Takeda Pharmaceutical Company Limited Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 99. Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Product Offered
Table 100. Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Takeda Pharmaceutical Company Limited Main Business
Table 102. Takeda Pharmaceutical Company Limited Latest Developments
Table 103. Sunesis Pharmaceuticals, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 104. Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 105. Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Sunesis Pharmaceuticals, Inc. Main Business
Table 107. Sunesis Pharmaceuticals, Inc. Latest Developments
Table 108. Agios Pharmaceuticals, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 109. Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 110. Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Agios Pharmaceuticals, Inc. Main Business
Table 112. Agios Pharmaceuticals, Inc. Latest Developments
Table 1. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Acute Myeloid Leukaemia Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Hypomethylating Agents
Table 7. Major Players of Others
Table 8. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Table 11. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Table 14. Global Acute Myeloid Leukaemia Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player (2021-2026)
Table 16. Acute Myeloid Leukaemia Therapeutics Key Players Head office and Products Offered
Table 17. Acute Myeloid Leukaemia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Table 22. Global Acute Myeloid Leukaemia Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country (2021-2026)
Table 26. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Table 28. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Table 30. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Table 32. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country (2021-2026)
Table 36. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Acute Myeloid Leukaemia Therapeutics
Table 42. Key Market Challenges & Risks of Acute Myeloid Leukaemia Therapeutics
Table 43. Key Industry Trends of Acute Myeloid Leukaemia Therapeutics
Table 44. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Pfizer Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 49. Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 50. Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Pfizer Inc. Main Business
Table 52. Pfizer Inc. Latest Developments
Table 53. Novartis AG Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 54. Novartis AG Acute Myeloid Leukaemia Therapeutics Product Offered
Table 55. Novartis AG Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Novartis AG Main Business
Table 57. Novartis AG Latest Developments
Table 58. Celgene Corporation Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 59. Celgene Corporation Acute Myeloid Leukaemia Therapeutics Product Offered
Table 60. Celgene Corporation Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Celgene Corporation Main Business
Table 62. Celgene Corporation Latest Developments
Table 63. Astellas Pharma Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 64. Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 65. Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Astellas Pharma Inc. Main Business
Table 67. Astellas Pharma Inc. Latest Developments
Table 68. Daiichi Sankyo Company, Limited Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 69. Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Product Offered
Table 70. Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Daiichi Sankyo Company, Limited Main Business
Table 72. Daiichi Sankyo Company, Limited Latest Developments
Table 73. Jazz Pharmaceuticals Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 74. Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Product Offered
Table 75. Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Jazz Pharmaceuticals Main Business
Table 77. Jazz Pharmaceuticals Latest Developments
Table 78. Boehringer Ingelheim International GmbH Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 79. Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Product Offered
Table 80. Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Boehringer Ingelheim International GmbH Main Business
Table 82. Boehringer Ingelheim International GmbH Latest Developments
Table 83. Johnson & Johnson Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 84. Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Product Offered
Table 85. Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Gilead Sciences, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 89. Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 90. Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Gilead Sciences, Inc. Main Business
Table 92. Gilead Sciences, Inc. Latest Developments
Table 93. Amgen Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 94. Amgen Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 95. Amgen Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Amgen Inc. Main Business
Table 97. Amgen Inc. Latest Developments
Table 98. Takeda Pharmaceutical Company Limited Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 99. Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Product Offered
Table 100. Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Takeda Pharmaceutical Company Limited Main Business
Table 102. Takeda Pharmaceutical Company Limited Latest Developments
Table 103. Sunesis Pharmaceuticals, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 104. Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 105. Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Sunesis Pharmaceuticals, Inc. Main Business
Table 107. Sunesis Pharmaceuticals, Inc. Latest Developments
Table 108. Agios Pharmaceuticals, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors
Table 109. Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered
Table 110. Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Agios Pharmaceuticals, Inc. Main Business
Table 112. Agios Pharmaceuticals, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Acute Myeloid Leukaemia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acute Myeloid Leukaemia Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Acute Myeloid Leukaemia Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Acute Myeloid Leukaemia Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Acute Myeloid Leukaemia Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type in 2025
Figure 10. Acute Myeloid Leukaemia Therapeutics in Specialty Clinics
Figure 11. Global Acute Myeloid Leukaemia Therapeutics Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 12. Acute Myeloid Leukaemia Therapeutics in Hospital
Figure 13. Global Acute Myeloid Leukaemia Therapeutics Market: Hospital (2021-2026) & ($ millions)
Figure 14. Acute Myeloid Leukaemia Therapeutics in Others
Figure 15. Global Acute Myeloid Leukaemia Therapeutics Market: Others (2021-2026) & ($ millions)
Figure 16. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application in 2025
Figure 17. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player in 2025
Figure 18. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 20. APAC Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 21. Europe Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Americas Acute Myeloid Leukaemia Therapeutics Value Market Share by Country in 2025
Figure 24. United States Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region in 2025
Figure 29. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Figure 31. China Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country in 2025
Figure 38. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 54. APAC Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 55. Europe Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. United States Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Canada Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. China Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Japan Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Korea Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. India Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Australia Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Germany Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. France Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. UK Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Italy Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Russia Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Israel Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 1. Acute Myeloid Leukaemia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acute Myeloid Leukaemia Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Acute Myeloid Leukaemia Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Acute Myeloid Leukaemia Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Acute Myeloid Leukaemia Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type in 2025
Figure 10. Acute Myeloid Leukaemia Therapeutics in Specialty Clinics
Figure 11. Global Acute Myeloid Leukaemia Therapeutics Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 12. Acute Myeloid Leukaemia Therapeutics in Hospital
Figure 13. Global Acute Myeloid Leukaemia Therapeutics Market: Hospital (2021-2026) & ($ millions)
Figure 14. Acute Myeloid Leukaemia Therapeutics in Others
Figure 15. Global Acute Myeloid Leukaemia Therapeutics Market: Others (2021-2026) & ($ millions)
Figure 16. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application in 2025
Figure 17. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player in 2025
Figure 18. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 20. APAC Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 21. Europe Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Americas Acute Myeloid Leukaemia Therapeutics Value Market Share by Country in 2025
Figure 24. United States Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region in 2025
Figure 29. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Figure 31. China Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country in 2025
Figure 38. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Acute Myeloid Leukaemia Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 54. APAC Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 55. Europe Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. United States Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Canada Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. China Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Japan Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Korea Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. India Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Australia Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Germany Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. France Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. UK Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Italy Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Russia Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Israel Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Acute Myeloid Leukaemia Therapeutics Market Size 2027-2032 ($ millions)
